Historique
Bulletin de Périodique
American Journal on Addictions , Vol.20, n°5 - September-October 2011
Paru le :
09/09/2011
Année :
2011
Page(s) :
397-493
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
• Improving temporal efficiency of outpatient buprenorphine induction. Gunderson E.W., Levin F.R., Rombone M.M., Vosburg S.K., Kleber H.D., p. 397-404.
• Personality disorders in gay, lesbian, bisexual, and transgender chemically dependent patients. Grant J.E., Flynn M., Odlaug B.L., Schreiber L.R., p. 405-411.
• Association of Substance Use and VA Service-Connected Disability Benefits with Risk of Homelessness among Veterans. Edens E.L., Kasprow W., Tsai J., Rosenheck R.A., p. 412-419.
• Psychological Distress, Binge/Heavy Drinking, and Gender Differences among Older Adults. Choi N.G., Dinitto D.M., p. 420-428.
• Correlates of alcohol abuse/dependence in early-onset alcohol-using women. Jenkins M.B., Agrawal A., Lynskey M.T., Nelson E.C., Madden P.A., Bucholz K.K., et al., p. 429-434.
• Persistent insomnia, abstinence, and moderate drinking in alcohol-dependent individuals. Brower K.J., Krentzman A., Robinson E.A., p. 435-440.
• A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers. Dakwar E., Nunes E.V., Bisaga A., Carpenter K.C., Mariani J.P., Sullivan M.A., et al., p. 441-446.
• The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina. Price K.L., Desantis S.M., Simpson A.N., Tolliver B.K., McRae-Clark A.L., Saladin M.E., et al., p. 447-455.
• Adding Voucher-Based Incentives to Community Reinforcement Approach Improves Outcomes during Treatment for Cocaine Dependence. Garcia-Fernandez G., Secades-Villa R., Garcia-Rodriguez O., Sanchez-Hervas E., Fernandez-Hermida J.R., Higgins S.T., p. 456-461.
• Predictors of smoking severity in patients with schizophrenia and alcohol use disorders. Meszaros Z.S., Dimmock J.A., Ploutz-Snyder R.J., Abdul-Malak Y., Leontieva L., Canfield K., et al., p. 462-467.
• Defining "binge" drinking as five drinks per occasion or drinking to a .08% BAC: Which is more sensitive to risk? Fillmore M.T., Jude R., p. 468-475.
• Consultation to the medically ill: a survey of addiction psychiatry fellowship programs. Suzuki J., Chang G., p. 476-477.
• A case report of concerta misuse in a patient with comorbid substance use disorder and attention deficit hyperactivity disorder. Rizkallah E., Legault L., Pampoulova T., Levesque S., Belanger M., Stavro K., et al., p. 478-479.
• Transdermal Buprenorphine to Switch Patients from Higher Dose Methadone to Buprenorphine without Severe Withdrawal Symptoms. Hess M., Boesch L., Leisinger R., Stohler R., p. 480-481.
• Evaluation of ethyl glucuronide immunoassay urinalysis in five alcohol-dependent outpatients. McDonell M.G., Srebnik D., Angelo F., Sugar A.M., Howell D., Rainey C., et al., p. 482-484.
• High-dose citalopram for cocaine dependence in veteran population-a pilot project. Vayalapalli S., Vaughn M., Salles-Shahid K., Byrd-Sellers J., Drexler K., p. 485-486.
• Financial motivation of smokers to quit smoking. Khalil R.B., Aoun-Bacha Z., Richa S., p. 487.
• Increased alcohol consumption rates of multiple sclerosis patients and their parents. Pehlivan M., Kurtuncu M., Yargic I., Tuzun E., p. 488-489.
• Methamphetamine, perceptual disturbances, and the peripheral drift illusion. Vila-Rodriguez F., Macewan G.W., Honer W.G., p. 490.
• Improving temporal efficiency of outpatient buprenorphine induction. Gunderson E.W., Levin F.R., Rombone M.M., Vosburg S.K., Kleber H.D., p. 397-404.
• Personality disorders in gay, lesbian, bisexual, and transgender chemically dependent patients. Grant J.E., Flynn M., Odlaug B.L., Schreiber L.R., p. 405-411.
• Association of Substance Use and VA Service-Connected Disability Benefits with Risk of Homelessness among Veterans. Edens E.L., Kasprow W., Tsai J., Rosenheck R.A., p. 412-419.
• Psychological Distress, Binge/Heavy Drinking, and Gender Differences among Older Adults. Choi N.G., Dinitto D.M., p. 420-428.
• Correlates of alcohol abuse/dependence in early-onset alcohol-using women. Jenkins M.B., Agrawal A., Lynskey M.T., Nelson E.C., Madden P.A., Bucholz K.K., et al., p. 429-434.
• Persistent insomnia, abstinence, and moderate drinking in alcohol-dependent individuals. Brower K.J., Krentzman A., Robinson E.A., p. 435-440.
• A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers. Dakwar E., Nunes E.V., Bisaga A., Carpenter K.C., Mariani J.P., Sullivan M.A., et al., p. 441-446.
• The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina. Price K.L., Desantis S.M., Simpson A.N., Tolliver B.K., McRae-Clark A.L., Saladin M.E., et al., p. 447-455.
• Adding Voucher-Based Incentives to Community Reinforcement Approach Improves Outcomes during Treatment for Cocaine Dependence. Garcia-Fernandez G., Secades-Villa R., Garcia-Rodriguez O., Sanchez-Hervas E., Fernandez-Hermida J.R., Higgins S.T., p. 456-461.
• Predictors of smoking severity in patients with schizophrenia and alcohol use disorders. Meszaros Z.S., Dimmock J.A., Ploutz-Snyder R.J., Abdul-Malak Y., Leontieva L., Canfield K., et al., p. 462-467.
• Defining "binge" drinking as five drinks per occasion or drinking to a .08% BAC: Which is more sensitive to risk? Fillmore M.T., Jude R., p. 468-475.
• Consultation to the medically ill: a survey of addiction psychiatry fellowship programs. Suzuki J., Chang G., p. 476-477.
• A case report of concerta misuse in a patient with comorbid substance use disorder and attention deficit hyperactivity disorder. Rizkallah E., Legault L., Pampoulova T., Levesque S., Belanger M., Stavro K., et al., p. 478-479.
• Transdermal Buprenorphine to Switch Patients from Higher Dose Methadone to Buprenorphine without Severe Withdrawal Symptoms. Hess M., Boesch L., Leisinger R., Stohler R., p. 480-481.
• Evaluation of ethyl glucuronide immunoassay urinalysis in five alcohol-dependent outpatients. McDonell M.G., Srebnik D., Angelo F., Sugar A.M., Howell D., Rainey C., et al., p. 482-484.
• High-dose citalopram for cocaine dependence in veteran population-a pilot project. Vayalapalli S., Vaughn M., Salles-Shahid K., Byrd-Sellers J., Drexler K., p. 485-486.
• Financial motivation of smokers to quit smoking. Khalil R.B., Aoun-Bacha Z., Richa S., p. 487.
• Increased alcohol consumption rates of multiple sclerosis patients and their parents. Pehlivan M., Kurtuncu M., Yargic I., Tuzun E., p. 488-489.
• Methamphetamine, perceptual disturbances, and the peripheral drift illusion. Vila-Rodriguez F., Macewan G.W., Honer W.G., p. 490.
Dépouillements
Ajouter le résultat à votre sélection
E. DAKWAR ;
E. V. NUNES ;
A. BISAGA ;
K. C. CARPENTER ;
J. P. MARIANI ;
M. A. SULLIVAN ;
W. N. RABY ;
F. R. LEVIN
|
2011
Dans American Journal on Addictions (Vol.20, n°5, September-October 2011) Article : Périodique
Dans American Journal on Addictions (Vol.20, n°5, September-October 2011) Article : Périodique
Depressive symptoms often coexist with substance use disorders (SUDs). The DSM-IV has identified two distinct categories for depression coexisting with SUDs-independent depression and substance-induced depression. While this distinction has impo[...]
M. T. FILLMORE ;
R. JUDE
|
2011
Dans American Journal on Addictions (Vol.20, n°5, September-October 2011) Article : Périodique
Dans American Journal on Addictions (Vol.20, n°5, September-October 2011) Article : Périodique
Heavy episodic or "binge" drinking is commonly defined as drinking 4-5 drinks per occasion (5/4 definition) or drinking that results in a blood alcohol concentration (BAC) of .08%. The present study compared the validity of each binge definition[...]
M. HESS ;
L. BOESCH ;
R. LEISINGER ;
R. STOHLER
|
2011
Dans American Journal on Addictions (Vol.20, n°5, September-October 2011) Article : Périodique
Dans American Journal on Addictions (Vol.20, n°5, September-October 2011) Article : Périodique
Buprenorphine has some advantages over methadone, such as missing evidence for QTc prolongation, possible alternate day dosing, limited respiratory depression, and a lower risk of overdosing. A transition from methadone to buprenorphine can beco[...]